Genetic: AAV5-hRKp.RPGR Low Dose clinical trials

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

This study is looking into a new gene therapy called AAV5-hRKp.RPGR for X-linked retinitis pigmentosa (XLRP). It's for people aged 3 and over with this eye condition, aiming to see if it can help improve or protect their vision. This is a follow-up trial.